WHC is still in active development. Read this to understand our approach.
depiction of CVHZOJJKTDOEJC-UHFFFAOYSA-N.svg
tripsit

lsa

Verificar en tripsit

psychonaut

LSA

Verificar en psychonaut

pubchem

Saccharin

Verificar en pubchem

druglab

LSA

Verificar en druglab

drugmap

Saccharin

Verificar en drugmap

Data

InChI: InChI=1S/C7H5NO3S/c9-7-5-3-1-2-4-6(5)12(10,11)8-7/h1-4H,(H,8,9)

Sinónimos: NSC5731,SACCHARIN [USP-RS],Spectrum5_001181,Soluble saccharin,2q38,Saccharin, soluble,Tox21_302950,HMS1921N03,IDI1_000164,1,2-Benzothiazol-3(2H)-one 1,1-dioxide,o-Benzosulphimide,NCGC00094918-03,Benzoic sulphimide,Benzosulphimide,BDBM29278,1,2-Benzisothiazol-3(2H)-one, 1,1-dioxide,2,3-dihydro-1$l^{6},2-benzothiazole-1,1,3-trione,2,3-Dihydro-3-oxo-Benzisosulfonazole, Benzosulfinide, Sucrette, o-Sulfobenzimide,AB00052233-04,Z256708526,2-Sulfobenzoic imide,1,2-Dihydro-2-ketobenzisosulphonazole,DSSTox_GSID_21251,1,1-dioxo-1,2-benzothiazol-3-one,Pharmakon1600-01501171,HMS500I06,o-Benzoic sulfimide;o-Sulfobenzimide,Spectrum4_000449,Saccharinol,1,2-Benzisothiazolin-3-one, 1,1-dioxide,Sykose,Benzo-2-sulphimide,Saccharine soluble,Kristallose,Sucromat,Sucrette,Saccharin (only persons who manufacture are subject, no supplier notification), Saccharin acid,KBio2_005829,Spectrum_000213,1, 2-Benzisothiazolin-3-one, 1,1-dioxide, sodium salt,1,1-Dioxide-1,2-benzisothiazol-3(2H)-one,Saccharin, >=99%,2-Sulfobenzoic acid imide,AKOS000120481,KBio2_000693,Crystallose,Sweeta (TN),1, 2-Benzisothiazol-3(2H)-one, 1,1-dioxide,Benzoylsulfonic Imide,Syncal,Sodium saccharinate,1, 2-Dihydro-2-ketobenzisosulfonazole,Saccharinum,SR-01000389315,Hermesetas,o-Sulfonbenzoic acid imide sodium salt, 81-07-2,CAS-81-07-2,EINECS 201-321-0,o-Sulfobenzoic acid imide,Spectrum3_001475,Sweeta,NSC 5731, Saccharine,SBI-0051671.P002,HSDB 669,DTXCID401251,NCGC00094918-05,03AC8EC2-D02A-464C-A7C3-7CABD643CC1E,BSPBio_003029,Saccharin [USAN],SACCHARIN [IARC], Saccharin insoluble, Gluside,NCGC00094918-02,Glucid,CHEMBL310671,1,2-Benzisothiazol-3(2H)-one 1,1-dioxide,E-954(I),NCGC00256329-01,NCGC00094918-09,NCGC00094918-04,STR03759, Saccharimide, Saxin,o-Sulfobenzimide,o-Benzoyl sulfimide,SACCHARIN [WHO-DD],NSC-757878,3-Benzisothiazolinone 1, 1-dioxide,Sacharin,UNII-FST467XS7D,DB12418,Tox21_111358,NCIOpen2_005180, Saccharina,128-44-9, Benzoic sulphimide,SACCHARIN [EP MONOGRAPH],1,1-Dioxo-1,2-dihydro-1lambda*6*-benzo[d]isothiazol-3-one,Saccharin (JP15/NF),HMS2092J09,SACCHARIN [FCC], Saccharinol,Saccharin (229 degrees C) Melting Point Standard,Willosetten,DSSTox_RID_76039,EC 201-321-0,2,3-dihydro-1lambda6,2-benzothiazole-1,1,3-trione,FT-0674494,Saxin,Tox21_111358_1, Sweeta,Tox21_201880,1286479-01-3,Saccharin and salts,3-Benzisothiazolinone 1,1-dioxide,Saccharin, United States Pharmacopeia (USP) Reference Standard,NSC4867,1,1-Dioxido-3-oxo-2,3-dihydrobenzo[d]isothiazole,Anhydro-o-sulfaminebenzoic acid,Saccharin, sodium salt,Natreen, 1,2-Benzisothiazol-3(2H)-one, 1,1-dioxide,NCGC00259429-01,NSC757878,CS-0013120,KBioGR_000838,Sacharin [Czech],Saccharin (IN-00581),Saccharin-13C6,W-200289,1,2-Benzisothiazolin-3-one 1,1-dioxide,SACCHARIN [MI],Rcra waste number U202,Neosaccharin,2,3-Dihydroxy-1,2-benzisothiazol-3-one-1,1-dioxide,Q191381,Glycophenol,1,2-Benzothiazol-3(2H)one 1,1-dioxide,Saccharin soluble,2,3-dihydro-1??,2-benzothiazole-1,1,3-trione,NSC5349,SACCHARIN [HSDB],1,2-benzisothiazoline-3-one-1,1-dioxide,M07 (saccharin),1.2-benzoisothiazole-3-on-1.1-dioxide,Saccharin acid,ulfonylurea TP3,Artificial sweetening substanz gendorf 450,1,1-Dioxo-1,2-benzisothiazol-3(2H)-one,Saccharin insoluble, Zaharina,1,1-Dioxo-1,2-dihydro-1lambda*6*-benzo[d]-isothiazol-3-one,EN300-18624,SCHEMBL3816,1,1-Dioxo-1,2-dihydro-benzo[d]isothiazol-3-one,hbmg,Benzo-sulphinide,1, 2-Benzisothiazolin-3-one 1,1-dioxide,BCP29068,WLN: T56 BSWMVJ,STK803263,s4819,SACCHARIN [VANDF],KBio3_002529,hbwr,Saccharin, puriss., 98%,2,3-Dihydro-3-oxobenzisosulphonazole,1,2-benzisothiazol-3(2H)-one,1,1-dioxide,hbw, Sucre edulcor,Saccharin [NF],HY-Y0272,SPBio_001564,SACCHARIN [JAN], Benzosulfimide,Sulfobenzimide, O-,Saccharin (JP17/NF),2,3-dihydro-3-oxo-1,2-benzisothiazol-1,1-dioxide,F0001-2092,1,2-Benzisothiazol-3(2H)-one 1,1-dioxide, 9CI, Saccharinose,Cristallose,Spectrum2_001432, Kandiset,Benzo[d]isothiazol-3(2H)-one 1,1-dioxide,550 Saccharine,2-Sulphobenzoic imide,NSC 5349, Benzoic sulfimide,NSC-5349,BBL015343,3-Hydroxybenzisothiazole-S,S-dioxide,SACCHARIN [MART.],SACCHARIN [INCI],saccharin, o-Sulfobenzoic acid im, o-Benzoic sulphimide,E954,1,1-Dioxide-1,2-benzisothiazolin-3-one,GTPL5432,SACCHARIN [II],1,2-Dihydro-2-ketobenzisosulfonazole, Garantose,Tolunene-2-sulfonamide,Benzisosulfonazole, 2,3-dihydro-3-oxo-,ZINC2560357,MFCD00005866,Benzoic sulfimide,Sodium 1,2 benzisothiazolin-3-one 1,1-dioxide,AB00052233_05,SACCHARINUM [HPUS],Sucre edulcor,KBio1_000164,Sodium saccharide,CCG-39011,Insoluble saccharin,DSSTox_CID_1251,Benzosulfimide, O-, Benzoylsulfonic Imide,D70140,Gluside,Sodium saccharine, Sacarina,1,1-Diox-1,2-benzisothiazol-3-one, o-Benzosulfimide,2,3-Dihydro-3-oxobenzisosulfonazole,Saccharin,BRD-K46493214-001-03-4,NINDS_000164,Mettler-Toledo Calibration substance ME 51143091, Saccharin,1,2-benzisothiazol-3(2H)-one-1,1-dioxide,Saccharin nitranion,2,3-Dihydro-1,2-benzoisothiazol-3-one-1,1-dioxide, Sykose,Benzo-2-sulfiide,Benzoic acid sulfimide, Saccharol,Saccharin, European Pharmacopoeia (EP) Reference Standard,2, 3-Dihydro-3-oxobenzisosulfonazole,o-sulphobenzoic imide,o-Benzoic sulphimide,Madhurin,o-Benzoic sulfimide,O-Benzoylsulfimide,NCIOpen2_005140,Sacarina,Kandiset,D01085,Sodium saccharin,Benzosulfimide,o-Benzoyl sulphimide,3-keto-2H,3H-1,2-benzisothiazole 1,1-dioxide,INS NO.954(I),1, 2-Benzothiazol-3(2H)-one 1,1-dioxide sodium salt,NCGC00094918-06,o-Benzosulfimide,morningglory,FT-0674493,KBioSS_000693,DTXSID5021251,Mettler-Toledo Calibration substance ME 51143091, Saccharin, traceable to primary standards (LGC), Benzo-2-sulphimide,1, 2-Benzisothiazol-3(2H)-one, 1,1-dioxide, sodium salt,Sodium o-benzosulfimide,INS-954(I),RCRA waste no. U202,Saccharin, >=98%,Zaharina,KBio2_003261,2-Sulfobenzoicimide,B0004,LSA,AI3-38107,Saccharin, insoluble,O-Sulfobenzoic imide,o-Benzoic acid sulfimide,NCGC00094918-07,1.2 -benzoisothiazole-3-on 1.1-dioxide,SPECTRUM1501171,Oxasulfuron metabolite, Hermesetas,Garantose,CHEBI:32111,Benzosulfinide,3-Hydroxybenzisothiazole S,S-dioxide,AKOS017272711,1,1-dioxo-1,2-dihydro-1lambda6-benzo[d]isothiazol-3-one,2,3-dihydro-1,2-benzisothiazol-3-one-1,1-dioxide,Saccharol,FST467XS7D,Saccharinose,Saccharimide,DivK1c_000164,ololiuqui,Saccharin, Pharmaceutical Secondary Standard; Certified Reference Material,SR-01000389315-2,NCGC00094918-01,1,2-Benzisothiazoline-3-one 1,1-dioxide, o-Benzoic sulfimide,morning_glory, o-Benzoyl sulfimide,SACCHARIN SODIUM,Saccharine,81-07-2, Benzosulphimide,Morning, Glucid


Estimated data

Solubilidad: -2.035 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: No (prediction using frontiersin.org)

Addictivity Prediction: 35.9% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.